Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 424.00
-8.00 (-1.85%)
Sep 16, 2026, 3:30 PM JST
Carna Biosciences Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,138 | 6,814 | 5,729 | 8,950 | 7,390 | 14,666 | |
Market Cap Growth | 115.46% | 18.93% | -35.99% | 21.11% | -49.61% | -2.43% |
Enterprise Value | 10,022 | 6,354 | 3,506 | 5,737 | 3,994 | 11,150 |
Last Close Price | 432.00 | 356.00 | 300.00 | 522.00 | 520.00 | 1102.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 137.38 | 137.38 | 137.38 | 137.38 | 137.38 |
PS Ratio | 12.53 | 11.77 | 9.01 | 5.51 | 5.33 | 7.27 |
PB Ratio | -22.40 | 22.12 | 2.32 | 2.31 | 2.03 | 3.40 |
P/TBV Ratio | - | 22.12 | 2.32 | 2.31 | 2.03 | 3.40 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 13.75 | 10.97 | 5.51 | 3.53 | 2.88 | 5.53 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -4.86 | 2.32 | 0.02 | 0.05 | 0.08 | 0.13 |
Net Debt / Equity Ratio | -2.17 | 0.64 | -0.83 | -0.70 | -0.85 | -0.76 |
Net Debt / EBITDA Ratio | - | -0.10 | 1.00 | 2.50 | 2.49 | 6.40 |
Net Debt / FCF Ratio | -0.42 | -0.09 | 1.48 | 1.60 | 3.69 | 2.08 |
Asset Turnover | 0.43 | 0.29 | 0.18 | 0.38 | 0.29 | 0.39 |
Inventory Turnover | 1.43 | 1.24 | 1.16 | 1.36 | 1.50 | 1.26 |
Quick Ratio | 8.69 | 3.67 | 9.89 | 9.81 | 8.17 | 6.54 |
Current Ratio | 12.14 | 6.99 | 12.33 | 11.18 | 9.41 | 6.87 |
Return on Equity (ROE) | -438.70% | -156.08% | -68.60% | -30.65% | -33.92% | -13.13% |
Return on Assets (ROA) | -72.68% | -64.83% | -36.44% | -16.21% | -16.37% | -6.46% |
Return on Invested Capital (ROIC) | -106.74% | -446.24% | -260.48% | -129.21% | -159.25% | -107.49% |
Return on Capital Employed (ROCE) | -121.70% | -195.60% | -81.40% | -28.10% | -33.20% | -11.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -23.57% | -31.86% | -38.02% | -12.87% | -18.25% | -3.64% |
FCF Yield | -22.89% | -31.82% | -24.21% | -18.86% | -11.29% | -10.75% |
Buyback Yield / Dilution | -2.86% | -6.71% | -6.61% | -23.37% | -7.26% | -3.22% |